Concepedia

Elina Asikanius

EA

Statistics

Publications

21

Citations

4.4K

H-Index

17

Active since

2010

Affiliations

Roche (Switzerland)(Current)

Nara Medical University

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

University of the Witwatersrand

Bloodworks Northwest

Elina Asikanius is an author at Roche (Switzerland) specializing in hematology, medicine, and clinical trials.

Top concepts

Publications per year

2010–2020

21

Publications

21

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

Valentin Goede, Kirsten Fischer, Raymonde Busch et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Johannes Oldenburg, Johnny Mahlangu, Benjamin Kim et al. · New England Journal of Medicine · 2017 · 1K citations · Full text

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

Johnny Mahlangu, Johannes Oldenburg, Ido Paz‐Priel et al. · New England Journal of Medicine · 2018 · 708 citations · Full text

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

Michael U. Callaghan, Claude Négrier, Ido Paz‐Priel et al. · Blood · 2020 · 270 citations · Full text

, , +15

Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study

Franck Morschhauser, Guillaume Cartron, Catherine Thiéblemont et al. · Journal of Clinical Oncology · 2013 · 201 citations · Full text

1–5 of 21